Description
Preface I. Overview of Hallucinogens 1. The Pharmacology of Psychedelics, David E. Nichols & Charles D. Nichols 2. Plants for the People: The Future of Psychedelic Therapies in the Age of Biomedicine, Dennis J. McKenna 3. Anthropology, Shamanism, and Hallucinogens, Michael Winkelman 4. A Short, Strange Trip: LSD Politics, Publicity, and Mythology--from Discovery to Criminalization, Maria Mangini 5. History of the Use of Hallucinogens in Psychiatric Treatment, Torsten Passie II. Neuroscience of Hallucinogens 6. Human Neuroimaging Studies of Serotonergic Psychedelics, Enzo Tagliazucchi 7. Memory Reconsolidation in Psycholytic Psychotherapy, Jim Grigsby III. Individual Hallucinogens 8. LSD, Kristine Panik & David E. Presti 9. Psilocybin, Stephen Ross, Silvia Franco, Collin Reiff, & Gabrielle Agin-Liebes 10. Therapeutic Potential of Fast-Acting Synthetic Tryptamines, Rafael Lancelotta & Alan K. Davis 11. Mescaline, Will Van Derveer 12. MDMA, Michael Mithoefer & Annie Mithoefer 13. Therapeutic and Social Uses of MDMA, Scott Shannon, Rob Colbert, & Shannon Hughes 14. Biological and Psychological Mechanisms Underlying the Therapeutic Use of Ayahuasca, Draulio Barros de Araujo, Luis Fernando Tofoli, Stevens Rehen, & Sidarta Ribeiro 15. The Ibogaine Project: Urban Ethnomedicine for Opioid Use Disorder, Kenneth Alper 16. Salvia divinorum, Ana Elda Maqueda 17. Ketamine, Gary Bravo, Robert Grant, & Raquel Bennett IV. Therapeutic Considerations 18. Set, Setting, and Dose, J. C. Callaway 19. The Use of Music in Psychedelic Therapy, Mendel Kaelen 20. The Role of the Guide in Psychedelic-Assisted Treatment, Mary Cosimano 21. Comparative Phenomenology and Neurobiology of Meditative and Psychedelic States of Consciousness: Implications for Psychedelic-Assisted Therapy, Milan Scheidegger 22. Adverse Effects, Kelan Thomas & Benjamin Malcolm V. Indications and Purpose 23. Utility of Psychedelics in the Treatment of Psychospiritual and Existential Distress in Palliative Care: A Promising Therapeutic Paradigm, Anthony P. Bossis 24. Classic Psychedelics for Treatment of Alcohol Use Disorder, Michael P. Bogenschutz & Sarah E. Mennenga 25. Psychedelics in the Treatment of Addiction, Matthew W. Johnson 26. The Treatment of Depressive Disorders with Psychedelics, Dave King & Jonny Martell 27. Hallucinogens in Headache, Emmanuelle A. D. Schindler VI. Mystical/Religious Experiences and Philosophical Considerations 28. Mystical/Religious Experiences with Psychedelics, William A. Richards 29. Philosophical Considerations Concerning the Use of Hallucinogens in Psychiatric Treatment, Candice L. Shelby
Charles S. Grob, MD, is Professor of Psychiatry and Pediatrics at the David Geffen School of Medicine at the University of California, Los Angeles, and Director of the Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center. He previously held faculty positions at the Johns Hopkins University and the University of California, Irvine. Dr. Grob has conducted approved clinical research with psychedelics since the early 1990s and has published numerous articles on psychedelics in the medical and psychiatric literatures, as well as several books. He is a founding board member of the Heffter Research Institute. Jim Grigsby, PhD, is Professor in the Department of Psychology, and in the Division of Health Care Policy and Research of the Department of Medicine, at the University of Colorado Denver. His research and over 250 publications have focused on neuropsychology, cognitive neuroscience, telemedicine, and other areas of health services research. His work in neuroscience includes extensive research on executive functioning and on the clinical phenotypes of fragile x-associated tremor/ataxia syndrome (FXTAS), of which he was a co-discoverer. Dr. Grigsbys current research interests include the the therapeutic use and mechanisms of psilocybin and MDMA.